Explore the vast range of titles available.

Dogs and cats in Brazil serve as primary hosts for a considerable number of parasites, which may affect their health and wellbeing. These may include endoparasites (e.g., protozoa, cestodes, trematodes, and nematodes) and ectoparasites (i.e., fleas, lice, mites, and ticks). While some dog and cat parasites are highly host-specific (e.g., Aelurostrongylus abstrusus and Felicola subrostratus for cats, and Angiostrongylus vasorum and Trichodectes canis for dogs), others may easily switch to other hosts, including humans. In fact, several dog and cat parasites (e.g., Toxoplasma gondii , Dipylidium caninum , Ancylostoma caninum , Strongyloides stercoralis , and Toxocara canis ) are important not only from a veterinary perspective but also from a medical standpoint. In addition, some of them (e.g., Lynxacarus radovskyi on cats and Rangelia vitalii in dogs) are little known to most veterinary practitioners working in Brazil. This article is a compendium on dog and cat parasites in Brazil and a call for a One Health approach towards a better management of some of these parasites, which may potentially affect humans. Practical aspects related to the diagnosis, treatment, and control of parasitic diseases of dogs and cats in Brazil are discussed.

Background Trichodectes canis is a small chewing louse found globally that primarily infests dogs. Limited information is available on the efficacy of isoxazolines against infestation with the chewing louse. In the present study, we evaluated the efficacy of afoxolaner, an isoxazoline class compound, in naturally infested domestic dogs. Methods The field study was carried out in Romania. Between September 2021 and December 2021, 43 dogs with confirmed T. canis infestation were included in the study. On the day of the inclusion (day 0), each animal was clinically examined and randomly treated with a control product labeled for use against lice [fipronil-(S)-methoprene combination (Frontline Combo®; Boehringer Ingelheim)] or with the investigational product [chewable tablets containing afoxolaner (NexGard®; isoxazoline)]. Each animal was evaluated for the presence of lice at 15 and 30 days post-inclusion. Results Of the 48 dogs initially included in the study, 43 completed the treatment period [18 in the control group (CG) and 25 in the investigational group (IG)]. At day 14, no living T. canis lice were detected on the dogs in either group. At day 14, dead lice were detected in four dogs in the IG, while eggs were present in two dogs in the IG and in one dog in the CG. At day 30, no lice were detected in either group, while eggs were still present in one dog in the CG. Conclusion These results suggest that afoxolaner is a feasible treatment option against chewing lice in dogs, providing 100% curative efficacy. Graphical Abstract

BACKGROUND: The studies reported here were conducted to ascertain the efficacy of imidacloprid/flumethrin incorporated in a slow-release matrix collar, against infestations of dogs by fleas, ticks, mites and lice. Efficacy was evaluated against the flea Ctenocephalides felis felis, the ticks Rhipicephalus sanguineus, Ixodes ricinus, Ixodes scapularis, Dermacentor reticulatus and Dermacentor variabilis, the mite Sarcoptes scabiei and the biting louse Trichodectes canis. METHODS: Groups of collar-treated dogs (n = 7–10) were infested with fleas and/or ticks at monthly intervals at least, over a period of up to 8 months. Efficacy against fleas was evaluated 24 to 48 h after treatment and 24 h after each re-infestation. Efficacy against ticks was evaluated at 48 h (acaricidal), 6 h (repellent) and 48 h (sustained) after infestation. The effect of regular shampooing or immersion in water on the efficacy of the collars was also tested. Efficacy against flea larvae was assessed by incubating blanket samples after dog contact with viable flea eggs. Effectiveness against lice and mites was evaluated after treatment of naturally infested animals. With the exception of the mites, efficacy was calculated by comparison with untreated negative control groups. RESULTS: Efficacy against fleas (24 h) generally exceeded 95%, and against flea larvae it exceeded 99% for 8 months. Sustained acaricidal (48 h) efficacy, covering a period of 8 months was 100% against I. ricinus, starting 2 days after treatment (in vivo), and 100% against I. scapularis (in vitro), above 97% against R. sanguineus, generally above 97% against D. reticulatus and above 90% for D. variabilis. Repellent (6 h) efficacy 2 days after treatment and continuing for 8 months was consistently 100% against I. ricinus, and above 90% against R. sanguineus. Regular shampooing affected efficacy against fleas and ticks to a lesser extent than regular immersion in water. The collars eliminated Trichodectes canis within 2 days and Sarcoptes scabiei within 3 months. CONCLUSION: The rapid insecticidal and acaricidal properties of the medicated collars against newly-acquired infestations of fleas and ticks and their sustained high levels of preventive efficacy have been clearly shown. Consequently they have the potential to prevent the transmission of vector-borne diseases and other conditions directly associated with infestation throughout an entire season of parasite abundance.

Biting dog lice (Trichodectes canis) were first detected on wolves (Canis lupus) in Southcentral Alaska (USA) in 1981 introduced via domestic dogs. Lice infestation expanded north via wolf dispersal to the Tanana Flats of Interior Alaska in December 2003. Effects of this ectoparasite on wolves were persistent with moderate to severe clinical signs of pediculosis lasting multiple generations. Our objectives were to evaluate the extent of lice infestation on wolves within the Tanana Flats and develop a management program that limited further transmission. We implemented a treatment method that consisted of multiple applications of oral antiparasitic ivermectin-injected baits aerially distributed at den and rendezvous sites during mid-May through August. During 2005—2010, we evaluated 12—19 packs annually as part of a treatment group and 3 infested packs as a control. Infestation rates of treatment packs prior to treatment varied from 15% in 2005 (2 of 13), 50% in 2006 (7 of 14), 24% in 2007 (4 of 17), 5% in 2008 (1 of 19), and 0% in 2009—2010 (0 of 19). We treated 50%, 71%, and 75% of the infested treatment packs during 2005—2007, respectively. All treated packs were lice-free the winter following treatment, whereas all 3 control packs remained infested. The combination of treatment and harvest successfully eliminated the local source population of lice within 3 years and we found no evidence of lice infestation within the treatment area during the last 3 years of the study. By using this treatment method, managers can eliminate dog lice infestations of wolves in areas ≤13,000 km². By initiating treatment promptly after detection, transmission to unexposed nearby packs can be postponed and the local source population of lice on wolves eradicated.

The presence of the dog biting louse, Trichodectes canis (De Geer, 1778; Ischnocera: Trichodectidae), is reported for the first time in the critically endangered Pseudalopex fulvipes (Martin, 1837) in Chiloé Island, south Chile.

Dog Lice frequently infest domestic dogs and other wild canids in North America. Gray Wolves infested with Dog Lice were identified on the Kenai Peninsula, Alaska in 1981-1983 in Interior Alaska near Denali National Park in 1999 and in Tanana Flats, south of Fairbanks, Alaska in 2003. Here, Jimenez et al report their first recorded cases of Dog Lice infesting 14 Wolves in 9 different packs in Montana and Idaho from 2005 through 2007. In 2006 and 2007, state veterinarians documented Idaho wolves infested with Dog Lice during necropsies performed at the Idaho Fish and Game wildlife Health Laboratory in Caldwell, Idaho. They stress that Dog Lice are difficult to diagnose by the naked eye unless specifically searched.

The efficacy of selamectin was evaluated against naturally acquired Trichodectes canis infestations on dogs and against Felicola subrostratus infestations on cats. Twenty dogs and 18 cats were randomly allocated to treatment with either a placebo or selamectin (6 mg/kg), administered topically once only on day 0. The treatment had no adverse effects in either the dogs or the cats. Efficacy was assessed by counting the live lice (adults and nymphs) on each animal by using a coat.parting technique on days -3, 7, 14, 21, 28, 35 and 42 for the dogs, and on days -1, 7,21, 35 and 42 for the cats. On day 43, the number of live lice on each dog was also assessed by using a whole.body combing technique. Selamectin was 100 per cent effective in killing biting lice on the dogs and cats throughout the period of assessment; the louse counts on the treated dogs and cats were significantly lower than the pretreatment counts (P=0.0001) and were also significantly lower than on the placebo.treated dogs (P≤0.05) and cats (P=0.0001). There was a marked reduction in the prevalence of clinical signs associated with ectoparasite infestation in the treated dogs and no clinical signs were observed in any of the treated cats.